EUVIMEDEUVIMED entdecken
Crossref

Perkembangan terkini dalam diagnosis dan penatalaksanaan Allergic Bronchopulmonary Aspergillosis (ABPA): tinjauan pustaka

I Desak Putu Agung Krisdanti, Putu Gita Indraswari

Intisari Sains Medis · 12.04.2026 · 17 (1) · 295-305

DOI: 10.15562/ism.v17i1.2656 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Intisari Sains Medis, online erschienen am 12.04.2026. Verfasst von I Desak Putu Agung Krisdanti und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Allergic bronchopulmonary aspergillosis (ABPA) is a complex immunologically mediated pulmonary disorder caused by hypersensitivity reactions to Aspergillus species, predominantly Aspergillus fumigatus. Despite being recognized for decades, ABPA remains frequently underdiagnosed, particularly in developing countries, leading to delayed treatment and irreversible lung damage such as bronchiectasis and pulmonary fibrosis.

Methods

This literature review synthesizes current evidence on the epidemiology, pathogenesis, clinical manifestations, diagnostic criteria, radiological features, and management of ABPA. Relevant publications were identified from major medical databases and international guidelines, with particular emphasis on the updated 2024 ISHAM-ABPA Working Group recommendations.

Results

ABPA primarily affects patients with asthma or cystic fibrosis but may also occur in individuals with other chronic airway diseases. Advances in immunological testing, especially serum total IgE and Aspergillus-specific IgE and IgG assays, along with high-resolution computed tomography, have improved diagnostic accuracy. Updated diagnostic criteria lower the serum total IgE threshold and broaden predisposing conditions, enhancing sensitivity for early detection. Management strategies emphasize systemic corticosteroids as first-line therapy, adjunctive antifungal agents for steroid-sparing effects, and emerging biologic therapies targeting type 2 inflammation in refractory or steroid-dependent cases.

Conclusion

ABPA remains a clinically challenging and underrecognized condition with significant long-term consequences if untreated. Early diagnosis using updated criteria and individualized treatment strategies is crucial to prevent disease progression and preserve lung function. Increased awareness and access to appropriate diagnostic tools are essential to improve outcomes, particularly in resource-limited settings. Latar Belakang: Allergic bronchopulmonary aspergillosis (ABPA) merupakan penyakit paru kronis akibat reaksi hipersensitivitas imun terhadap jamur Aspergillus, terutama Aspergillus fumigatus. Meskipun telah lama dikenal, ABPA masih sering tidak terdiagnosis, khususnya di negara berkembang, sehingga meningkatkan risiko kerusakan paru ireversibel seperti bronkiektasis dan fibrosis paru. Metode: Tinjauan pustaka ini merangkum perkembangan terkini terkait epidemiologi, patogenesis, manifestasi klinis, kriteria diagnosis, temuan radiologis, serta tatalaksana ABPA. Literatur diperoleh dari basis data medis utama dan pedoman internasional, dengan fokus pada pembaruan pedoman ISHAM-ABPA Working Group tahun 2024. Hasil: ABPA terutama terjadi pada pasien dengan asma dan cystic fibrosis, namun juga dapat ditemukan pada penyakit saluran napas kronis lainnya. Kemajuan pemeriksaan imunologi, khususnya IgE total serum serta IgE dan IgG spesifik Aspergillus, dikombinasikan dengan HRCT toraks, meningkatkan akurasi diagnosis. Kriteria diagnostik terbaru menurunkan ambang IgE total dan memperluas kondisi predisposisi, sehingga memungkinkan deteksi dini. Penatalaksanaan menekankan penggunaan kortikosteroid sistemik sebagai terapi utama, antifungal sebagai strategi steroid-sparing, serta terapi biologik pada kasus refrakter atau steroid-dependent. Simpulan: ABPA merupakan penyakit kompleks yang memerlukan pendekatan diagnostik dan terapeutik yang tepat serta individual. Penerapan kriteria diagnosis terkini dan terapi yang sesuai dapat mencegah progresivitas penyakit dan mempertahankan fungsi paru. Peningkatan kesadaran klinisi dan akses terhadap pemeriksaan penunjang sangat penting untuk memperbaiki luaran pasien.

Zitieren

APA

Krisdanti, I. D. P. A., & Indraswari, P. G. (2026). Perkembangan terkini dalam diagnosis dan penatalaksanaan Allergic Bronchopulmonary Aspergillosis (ABPA): tinjauan pustaka. Intisari Sains Medis, 17(1), 295-305. https://doi.org/10.15562/ism.v17i1.2656

Vancouver

Krisdanti IDPA, Indraswari PG. Perkembangan terkini dalam diagnosis dan penatalaksanaan Allergic Bronchopulmonary Aspergillosis (ABPA): tinjauan pustaka. Intisari Sains Medis. 2026;17(1):295-305. doi:10.15562/ism.v17i1.2656

BibTeX
@article{Krisdanti2026,
  author = {Krisdanti, I Desak Putu Agung and Indraswari, Putu Gita},
  title = {Perkembangan terkini dalam diagnosis dan penatalaksanaan Allergic Bronchopulmonary Aspergillosis (ABPA): tinjauan pustaka},
  journal = {Intisari Sains Medis},
  year = {2026},
  volume = {17},
  number = {1},
  pages = {295--305},
  doi = {10.15562/ism.v17i1.2656}
}
Kostenlos starten →